April 26, 2022
Aperion Biologics create invIOs Holding through demerger
APEIRON Biologics AG has announced that the annual general meeting held yesterday has approved the new structure of the group…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Aperion Biologics
April 2, 2020
Austrian Aperion OKd to phase2 test APN01 to treat COVID-19 in 3 EU countries
Apeiron Biologics AG has received regulatory approvals in Austria, Germany and Denmark to kickoff a Phase II clinical trial of APN01 to treat COVID-19.